Medical Injection Molding Case Studies:
CTQ, Validation & Quality Evidence
Three project examples showing how CTQ definition,
inspection records, material traceability and
validation-support evidence are reviewed during
medical molding development.
These
medical injection molding case studies
focus on the manufacturing evidence engineering and
sourcing teams typically review when a molded component
includes sealing surfaces, thin-wall geometry,
fit-critical interfaces, overmold boundaries or
traceability requirements.
The three examples cover a catheter connector,
a thin-wall drug-delivery housing and a
two-shot medical component.
Each case connects the identified project risk to the
relevant CTQ, inspection method and supporting records,
including drawing-based FAI, dimensional or optical
inspection, material documentation and trial-stage
evidence where specified.
Each case is organized around the project condition,
the CTQ that required control, the inspection method
used to evaluate it and the evidence available for
engineering review.
Summary of medical injection molding case projects,
CTQ requirements, inspection methods and evidence reviewed.
Case Project
Resin / Process Review
CTQ Focus
Inspection Method
Evidence to Review
Catheter Connector
Specified resin and overmolding
compatibility review
Sealing diameter,
tubing-retention area,
overmold interface and
potential leak-path geometry
Dimensional inspection,
interface review and
leak or pressure verification
where specified
FAITrial RecordMaterial Cert
Drug-Delivery Housing
Resin behavior,
thin-wall stability and
feature-fill review
Sealing-face flatness,
snap-fit position,
micro-feature definition and
assembly alignment
Optical measurement,
CMM inspection,
feature review and
drawing-based FAI
where required
Material CertCoCFAI
Two-Shot Medical Component
Two-shot molding review
for rigid-soft interface
and shot-to-shot alignment
Interface consistency,
flash control,
assembly fit and
material-traceability boundary
Assembly-force check,
fit verification,
interface inspection and
traceability review
Lot TraceabilityValidation SupportCoC
Validation scope:
This page shows project-level evidence rather than a complete
mold-validation procedure. For the broader validation framework,
see the
injection mold validation guide
.
Medical Molding Case 01
Catheter Connector Overmolding with Sealing Interface Control
Sealing interface, tubing-retention geometry and
overmold coverage identified as functional CTQ areas.
Project Background & Functional Risk
This project involved a disposable catheter connector with
a molded connection interface and an overmolded grip area.
The engineering review concentrated on the interfaces that
could influence sealing, tubing retention, assembly fit and
overmold consistency rather than treating all molded features
as equal-risk dimensions.
Critical-to-Quality Features
Before tooling release, the functional interfaces were
separated from general cosmetic dimensions and identified
as Critical-to-Quality (CTQ) features.
The review focused on:
Sealing diameter:
mating diameter, roundness and datum relationship
against the drawing and interface requirements.
Tubing-retention geometry:
barb definition, pitch consistency and areas where
flash could affect assembly or retention.
Overmold interface:
coverage, flash, void or incomplete-fill risk and
other conditions that could affect the functional
interface.
Functional retention:
pull-off or mechanical-retention criteria only where
a customer-defined test method and acceptance limit
were specified.
Inspection-fixture concept for sealing-interface
verification where functional testing was specified.
Manufacturing Review & Process Response
The molding review covered substrate and overmold
compatibility, resin handling, the bonding-interface
condition, gate and venting strategy, flash-sensitive
geometry and the records required to preserve material
and production traceability. These reviews were tied back
to the CTQ interfaces rather than treated as independent
process checks.
Inspection & Evidence Package
The inspection plan prioritized evidence connected to
sealing, tubing retention, overmold coverage and
traceability. Depending on drawing and customer
requirements, the review could include:
Functional verification:
leak, pressure or retention testing only where the
customer supplied the test method and acceptance
criteria.
Material and lot records:
material certificate, resin lot, cavity or production
identification and drawing revision where required.
Trial-stage evidence:
tooling observations, flash or coverage issues and
documented corrective actions retained through the
agreed trial history.
Functional Risk
Sealing, tubing retention and
overmold-interface consistency
Primary CTQ
Sealing diameter, retention geometry
and overmold coverage
Evidence
Dimensional FAI, material records
and specified functional checks
Engineering Lesson
Functional interfaces should be
defined before tooling decisions are frozen
Evidence boundary:
device-level acceptance criteria, leak or pressure limits,
retention limits, sterilization requirements and regulatory
validation remain customer-defined. SPI's scope in this case
is manufacturing-feasibility review, tooling and molding
support, inspection evidence, traceability records and agreed
validation-support documentation.
Medical Molding Case 02
Thin-Wall Drug-Delivery Housing with Micro-Feature
& Fit Control
Optical inspection focused on micro-features,
snap-fit geometry and fit-critical molded interfaces.
Project Background & Functional Risk
This case involved a drug-delivery housing with thin-wall
sections, small molded features, snap-fit interfaces and
fit-critical alignment surfaces. The engineering review
focused on dimensional shift, warpage, incomplete filling,
flash and tolerance interaction because these conditions
could affect assembly fit and interface alignment even when
the molded part appeared visually acceptable.
Critical-to-Quality Features
Before tooling release, the drawing and assembly interfaces
were reviewed to identify the features that required
CTQ-level control. The primary areas were:
Sealing face and snap-fit interfaces:
flatness, engagement geometry and interface location
relative to the drawing datum structure.
Micro ribs and alignment bosses:
feature definition and areas susceptible to incomplete
fill, flash or gas-trap conditions.
Tolerance interaction:
mating dimensions reviewed together so an individual
dimensional pass would not conceal an assembly-fit or
alignment problem.
Warpage-sensitive geometry:
thin-wall sections, wall transitions and fit-critical
surfaces where molding variation could shift the
functional interface.
Tooling & Process Response
The tooling and molding review concentrated on the process
conditions most closely connected to those CTQs. Gate
position and flow direction were reviewed against thin-wall
sections and small features, while venting attention was
directed toward rib ends, bosses and flow-end regions.
Thermal balance, resin flow behavior and trial-stage defect
observations were then considered when deciding whether a
tooling or process correction was required.
Inspection & Evidence Package
Inspection methods were selected according to feature size,
accessibility, datum structure and drawing requirements
rather than assigning one metrology method to every feature.
The project evidence could include:
Optical inspection:
small-feature definition, flash-sensitive regions,
snap-fit geometry and other visually accessible CTQs.
Dimensional metrology:
CMM, optical measurement or fixture-based checks
selected according to datum logic and feature access.
Drawing-based FAI:
fit-critical dimensions, sealing surfaces, alignment
features and drawing-revision status where required.
Traceability records:
material documentation, CoC, trial-stage notes and
production records only where supported by the
actual project scope.
Functional Risk
Thin-wall variation, warpage and
fit-critical interface shift
Primary CTQ
Sealing faces, snap fits,
micro-features and alignment geometry
Evidence
Optical inspection, dimensional FAI
and traceability records
Engineering Lesson
Visual acceptance alone does not confirm
functional interface conformity
Medical Molding Case 03
Two-Shot Medical Component with Rigid-Soft
Interface Control
Two-shot molding review focused on interface alignment,
material transition and repeatability.
Project Background & Interface Risk
This case involved a syringe-related multi-material
component with a rigid body and a soft functional
interface. The main engineering risk was not simply
molding two materials in one part, but maintaining
shot-to-shot alignment, interface consistency,
flash control and assembly-fit behavior across the
rigid-soft transition.
Critical-to-Quality Features
The project review identified the interface conditions
most likely to influence assembly and function and treated
them as CTQ features:
Interface alignment:
shot-to-shot registration and positioning at the
rigid-soft transition.
Locking features:
engagement geometry linked to the drawing datum
structure, assembly intent and customer-defined
acceptance requirements.
Material transition:
continuity of the rigid-soft boundary, flash,
incomplete fill and other visible or functional
interface defects.
Specified soft-material condition:
hardness and surface characteristics controlled
against the approved material specification rather
than subjective tactile judgment.
Assembly function:
retention, engagement or release behavior only
where a customer-defined test method and acceptance
criterion were provided.
Rigid-soft transition, locking geometry and
flash-sensitive interface reviewed as functional CTQs.
Two-Shot Process Response
The manufacturing review linked material pairing,
part positioning and second-shot alignment back to the
defined interface CTQs. Trial-stage observations were
used to review fill condition, flash, registration and
interface stability before production-intent release,
with tooling or process correction considered where
those observations affected the agreed requirements.
Inspection, Traceability & Change Control
The evidence package connected interface quality with
dimensional inspection, material traceability and
revision control. This was important because a change
to material, tooling or process conditions could affect
both shot alignment and rigid-soft interface behavior.
Interface inspection:
flash, registration, transition condition and
visible interface defects reviewed against the
agreed drawing or project criteria.
Dimensional inspection:
CMM, optical measurement or fixture-based checks
selected according to feature accessibility,
datum structure and drawing requirements.
Material and lot traceability:
material lot, production identification, tooling
revision and drawing revision linked through the
agreed manufacturing records where required.
Engineering change control:
tooling, material, process or acceptance-criteria
changes reviewed before release under the agreed
production-control process.
Functional Risk
Shot alignment, flash and
rigid-soft interface inconsistency
Primary CTQ
Interface registration,
locking geometry and transition quality
Evidence
Interface inspection, dimensional records
and material traceability
Engineering Lesson
Multi-material molding must control the
interface, not only each individual material
Evidence & Responsibility Boundary
Medical Molding Scope:
Manufacturing Support vs. Device-Level Responsibility
The case studies above document manufacturing risks,
CTQ review, inspection, traceability and agreed project
records. They do not replace the customer's device-level
design, regulatory or final product responsibilities.
Keeping that boundary clear prevents manufacturing
evidence from being interpreted as device approval.
SPI Manufacturing Scope
Manufacturing & Quality Evidence
Tooling and molding feasibility review against
the agreed drawing, CTQs and project requirements.
Dimensional and visual inspection against defined
datums, drawings and inspection requirements.
Material, production, cavity, tooling or revision
traceability where included in the agreed scope.
FAI, dimensional reports, material certificates,
CoC and other manufacturing records where required
and supported by the project.
Trial-stage and validation-support documentation
only where specifically defined for the program.
Customer / OEM Scope
Device-Level Decisions & Acceptance
Final device design, intended use and device-level
risk-management decisions.
Regulatory strategy, submissions, registrations
and product-approval decisions.
Final device verification, validation and
product-safety acceptance.
Sterilization, biocompatibility and other
end-use qualification requirements.
Final acceptance criteria and legal-manufacturer
responsibilities applicable to the finished device.
Scope clarification:
the exact inspection, traceability and documentation package
depends on the customer's drawing, quality requirements,
purchase documentation and approved project scope. The
manufacturing evidence shown on this page should therefore
be read as project-level production support, not as
device-level regulatory approval.
FAQ for Medical Molding Case Review & RFQ Preparation
These questions focus on the information needed to compare
a new medical molding project with the case evidence above
and prepare a more complete engineering or quotation review.
RFQ Input
What files should be submitted before a medical injection molding RFQ?
A useful RFQ package normally includes the current
3D CAD model, revision-controlled 2D drawing,
specified resin, estimated production volume,
tooling intent and clearly identified CTQs.
Fit-critical interfaces, sealing surfaces,
overmold boundaries and inspection requirements
should be marked before DFM and quotation review.
CTQ Definition
Which requirements should be identified as CTQs before tooling release?
CTQs should be tied to functional risk rather than
every drawing dimension. Examples from the cases
above include sealing diameters, snap-fit geometry,
alignment features, overmold interfaces and
rigid-soft transitions. The drawing, datum logic
and inspection method should make each agreed CTQ
measurable and reviewable.
Supplier Evidence
What evidence can buyers review before supplier approval?
The evidence should connect the drawing and CTQs
with manufacturing and inspection records. Depending
on project scope, this can include DFM or trial notes,
dimensional FAI, CMM or optical inspection results,
material certificates, CoC, traceability records and
revision-controlled documentation. Claims should be
supported by actual project records.
Production Route
When should a project avoid moving directly into production tooling?
Production tooling may be premature while geometry,
mating interfaces, resin, CTQs or expected volume
are still changing. In that situation, the next
decision is not explained on this case page; compare
the available
prototype, bridge and production routes
before committing to the production mold.
RFQ scope:
project requirements should come from the approved drawing,
material specification and customer quality requirements.
The examples on this page show manufacturing evidence and
review logic; they do not establish device-level regulatory
or final functional acceptance criteria.
Prepare Your Project
Request a Medical Injection Molding Engineering Review
If your project has defined geometry, material requirements
and functional CTQs, send the available design and production
information for manufacturability, tooling and inspection review.
The more clearly the critical interfaces and evidence requirements
are defined, the more focused the engineering review can be.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.